Literature DB >> 22344341

Adiponectin and interleukin-6 levels in insulin-treated diabetic rats with experimental periodontitis.

Ioanna Xynogala1, Eudoxie Pepelassi, Despina Perrea, George Agrogiannis, Alkistis Pantopoulou, Efstratios Patsouris, Ioannis Vrotsos.   

Abstract

The aim of the study was to compare the serum levels of adiponectin and interleukin-6 (IL-6) in insulin-treated diabetic rats with or without periodontitis. Forty male Wistar rats were randomly divided into 2 groups (20 rats each): a) insulin-treated diabetic group (control, DI) and b) insulin-treated diabetic periodontitis group (test, DIP). Diabetes was induced, and insulin treatment was initiated on day 5. On day 16, periodontitis was induced in the DIP group. All rats were euthanized on day 77. Adiponectin and IL-6 were assessed on days 16 and 77. At the end of the experiment, 14 and 11 rats survived in the DI and DIP groups, respectively. Adiponectin levels were statistically significantly higher at the end of the experiment compared with levels on day 16 in the periodontitis group (p < 0.05), but not in the control group. At the end of the experiment, adiponectin levels were statistically significantly higher in the periodontitis group compared with the control group (p < 0.05). Within-group and between-group comparisons of IL-6 levels showed no statistically significant difference. In conclusion, serum adiponectin was increased in insulin-treated diabetic rats with periodontitis in comparison with insulin-treated diabetic rats, while IL-6 levels did not differ between groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22344341     DOI: 10.1590/s1806-83242012000100012

Source DB:  PubMed          Journal:  Braz Oral Res        ISSN: 1806-8324


  1 in total

1.  Therapeutic Potential of Liraglutide for Diabetes-Periodontitis Comorbidity: Killing Two Birds with One Stone.

Authors:  Man Yang; Yunqing Pang; Minyu Pei; Yuanyuan Li; Xuemin Yuan; Rongbing Tang; Jing Wang
Journal:  J Diabetes Res       Date:  2022-07-06       Impact factor: 4.061

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.